Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $59.5 million.

  • Cryo Cell International's Other Non-Current Liabilities rose 813.15% to $59.5 million in Q3 2025 from the same period last year, while for Aug 2025 it was $59.5 million, marking a year-over-year increase of 813.15%. This contributed to the annual value of $56.3 million for FY2024, which is 954.72% up from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's Other Non-Current Liabilities is $59.5 million, which was up 813.15% from $58.2 million recorded in Q2 2025.
  • Cryo Cell International's 5-year Other Non-Current Liabilities high stood at $77.1 million for Q1 2021, and its period low was $34.2 million during Q1 2022.
  • Its 5-year average for Other Non-Current Liabilities is $49.3 million, with a median of $51.2 million in 2023.
  • Per our database at Business Quant, Cryo Cell International's Other Non-Current Liabilities surged by 12248.34% in 2021 and then plummeted by 5568.95% in 2022.
  • Over the past 5 years, Cryo Cell International's Other Non-Current Liabilities (Quarter) stood at $35.4 million in 2021, then surged by 32.56% to $46.9 million in 2022, then increased by 9.5% to $51.4 million in 2023, then grew by 9.55% to $56.3 million in 2024, then rose by 5.78% to $59.5 million in 2025.
  • Its last three reported values are $59.5 million in Q3 2025, $58.2 million for Q2 2025, and $57.3 million during Q1 2025.